These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 8848989)
1. Indapamide regresses, but transdermal clonidine does not regress, left ventricular hypertrophy in hypertensive diabetic patients. Tan SA; Berk LS; Tan LG Am J Cardiol; 1996 Feb; 77(6):20B-22B. PubMed ID: 8848989 [TBL] [Abstract][Full Text] [Related]
2. Effect of indapamide on left ventricular hypertrophy in hypertension: a meta-analysis. Carey PA; Sheridan DJ; de Cordoue A; Guez D Am J Cardiol; 1996 Feb; 77(6):17b-19b. PubMed ID: 8848988 [TBL] [Abstract][Full Text] [Related]
3. Regression of left ventricular hypertrophy in hypertensive patients treated with indapamide SR 1.5 mg versus enalapril 20 mg: the LIVE study. Gosse P; Sheridan DJ; Zannad F; Dubourg O; Guéret P; Karpov Y; de Leeuw PW; Palma-Gamiz JL; Pessina A; Motz W; Degaute JP; Chastang C J Hypertens; 2000 Oct; 18(10):1465-75. PubMed ID: 11057435 [TBL] [Abstract][Full Text] [Related]
4. Regression of left ventricular hypertrophy in patients with essential hypertension. Results of 6 month treatment with indapamide. Curry CL; Robinson H; Brown R; Olivan J; Sami M; Honos G; Ruddy TD; Balazovjech I; Touzek F; Galinier F; Mariani M; de Cordoüe A; Barrandon S; Brault Y; Guez D Am J Hypertens; 1996 Aug; 9(8):828-32. PubMed ID: 8862231 [TBL] [Abstract][Full Text] [Related]
5. Left ventricular hypertrophy in hypertensive patients in Indian primary care: prevalence and effect of treatment with sustained release indapamide. Lokhandwala Y; Damle A Curr Med Res Opin; 2004 May; 20(5):639-44. PubMed ID: 15140328 [TBL] [Abstract][Full Text] [Related]
6. [Effect of twelve-month combined therapy with perindopril and indapamide on the level of blood pressure and left ventricular hypertrophy in patients with hypertensive disease]. Timofeeva LA; Alekhin MN; Ugriumov MO; Chumakova OS; Larina VN; Sidorenko BA Kardiologiia; 2006; 46(3):30-4. PubMed ID: 16710252 [TBL] [Abstract][Full Text] [Related]
7. Left ventricular hypertrophy regression: the LIVE trial. Sheridan DJ Cardiologia; 1999 Dec; 44 Suppl 1(Pt 2):541-3. PubMed ID: 12497780 [TBL] [Abstract][Full Text] [Related]
8. Effects of indapamide on left ventricular mass and function in systemic hypertension with left ventricular hypertrophy. Komajda M; Klimczak K; Boutin B; Brackman F; Guez D; Grosgogeat Y Am J Cardiol; 1990 May; 65(17):37H-42H. PubMed ID: 2139541 [TBL] [Abstract][Full Text] [Related]
9. [Management of hypertensive patients with left ventricular hypertrophy]. Ambrosioni E Presse Med; 2002 Oct; 31 Spec No 2():S13-6. PubMed ID: 12355999 [TBL] [Abstract][Full Text] [Related]
10. Clinical implications of indapamide sustained release 1.5 mg in hypertension. Donnelly R Clin Pharmacokinet; 1999; 37 Suppl 1():21-32. PubMed ID: 10491730 [TBL] [Abstract][Full Text] [Related]
11. Regression of left ventricular hypertrophy in hypertension with indapamide. Sami M; Haichin R Am Heart J; 1991 Oct; 122(4 Pt 2):1215-8. PubMed ID: 1833967 [TBL] [Abstract][Full Text] [Related]
12. Comparative effects of indapamide and captopril on blood pressure and albumin excretion rate in diabetic microalbuminuria. Donnelly R; Molyneaux LM; Willey KA; Yue DK Am J Cardiol; 1996 Feb; 77(6):26B-30B. PubMed ID: 8848991 [TBL] [Abstract][Full Text] [Related]
13. Efficacy of very low dose perindopril 2 mg/indapamide 0.625 mg combination on left ventricular hypertrophy in hypertensive patients: the P.I.C.X.E.L. study rationale and design. Gosse P; Dubourg O; Guéret P; De Simone G; Schmieder R; De Leeuw PW; Degaute JP; García Puig J; Karpov Y; Magometschnigg D; Matos L; Amouyel P; Asmar R; Le Heuzey JY; Nieminen M; Dahlöf B J Hum Hypertens; 2002 Sep; 16(9):653-9. PubMed ID: 12214263 [TBL] [Abstract][Full Text] [Related]
14. Indapamide in the diabetic hypertensive. Guez D; Brackman F Arch Intern Med; 1988 Sep; 148(9):2073, 2077. PubMed ID: 3415408 [No Abstract] [Full Text] [Related]
15. Comparison of the effects of angiotensin receptor antagonist, angiotensin converting enzyme inhibitor, and their combination on regression of left ventricular hypertrophy of diabetes type 2 patients on recent onset hemodialysis therapy. Suzuki H; Kanno Y; Kaneko K; Kaneko M; Kotaki S; Mimura T; Takane H Ther Apher Dial; 2004 Aug; 8(4):320-7. PubMed ID: 15274684 [TBL] [Abstract][Full Text] [Related]
16. Effects of four antihypertensive monotherapies on cardiac mass and function in hypertensive patients with left ventricular hypertrophy: randomized prospective study. Rakić D; Rumboldt Z; Bagatin J; Polić S Croat Med J; 2002 Dec; 43(6):672-9. PubMed ID: 12476475 [TBL] [Abstract][Full Text] [Related]
17. Left Ventricular Hypertrophy in Hypertensive Athletes can be Reduced by Antihypertensive Medication Despite Continuing Intense Aerobic Exercise. Ketelhut S; Franz IW; Ketelhut RG High Blood Press Cardiovasc Prev; 2018 Dec; 25(4):385-390. PubMed ID: 30341642 [TBL] [Abstract][Full Text] [Related]
18. Regression of left ventricular mass in hypertensive patients treated with perindopril/indapamide as a first-line combination: the REASON echocardiography study. de Luca N; Mallion JM; O'Rourke MF; O'Brien E; Rahn KH; Trimarco B; Romero R; De Leeuw PW; Hitzenberger G; Battegay E; Duprez D; Sever P; Safar ME Am J Hypertens; 2004 Aug; 17(8):660-7. PubMed ID: 15323062 [TBL] [Abstract][Full Text] [Related]
19. Effects of additional administration of low-dose indapamide on patients with hypertension treated with angiotensin II receptor blocker. Yamada H; Mishiro Y; Kusunose K; Sata M J Cardiovasc Pharmacol Ther; 2010 Jun; 15(2):145-50. PubMed ID: 20200326 [TBL] [Abstract][Full Text] [Related]
20. Centralized echocardiogram quality control in a multicenter study of regression of left ventricular hypertrophy in hypertension. Gosse P; Guez D; Guéret P; Dubourg O; Beauchet A; de Cordoüe A; Barrandon S J Hypertens; 1998 Apr; 16(4):531-5. PubMed ID: 9797199 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]